Clinical Trials
3 trialsNCT07030140 2026-05-01
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
Shandong Cancer Hospital and Institute
Phase 2 Recruiting
NCT06493734 2025-07-15
STRONG II
Erasmus Medical Center
Phase NA Recruiting
NCT03307538 2021-01-26
STRONG
Erasmus Medical Center
Phase NA Completed